Upgrade to SI Premium - Free Trial

Eaton Vance Tax-advantaged Dividend Income Fund (EVT)

28.23 +0.24 (0.86%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds September 1, 2026 4:15 PM - BizWire Eaton Vance Closed-End Funds Release Estimated Sources of Distributions August 31, 2026 4:15 PM - BizWire Form 6-K Evotec SE For: Aug 13 August 13, 2026 6:07 AM - SEC Filing Evotec and Odyssey partner on autoimmune drug discovery August 6, 2026 6:00 AM - StreetInsider Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases August 6, 2026 2:17 AM - PR NewsWire Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds August 3, 2026 4:30 PM - BizWire Form N-PX Eaton Vance Tax-Advantag For: Jun 30 August 3, 2026 1:26 PM - SEC Filing Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 August 3, 2026 8:32 AM - BizWire Eaton Vance Closed-End Funds Release Estimated Sources of Distributions July 31, 2026 2:30 PM - BizWire Evotec selects Navan to manage travel and expense globally July 23, 2026 3:29 AM - StreetInsider Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management July 23, 2026 3:00 AM - BizWire Form 6-K Evotec SE For: Jul 13 July 14, 2026 6:01 AM - SEC Filing Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook July 13, 2026 3:44 PM - PR NewsWire Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds July 1, 2026 4:05 PM - BizWire Eaton Vance Closed-End Funds Release Estimated Sources of Distributions June 30, 2026 4:05 PM - BizWire Form 6-K Evotec SE For: Jun 30 June 30, 2026 1:01 PM - SEC Filing Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics June 30, 2026 2:17 AM - PR NewsWire Full Article List